Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer

被引:56
|
作者
Verhage, BAJ
van Houwelingen, K
Ruijter, TEG
Kiemeney, LA
Schalken, JA
机构
[1] Univ Nijmegen, Med Ctr, Dept Epidemiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
关键词
prostate cancer; E-cadherin; promoter; single-nucleotide polymorphism; hereditary;
D O I
10.1002/ijc.10541
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SN P at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 controls were genotyped. Genotype and allele frequencies differed significantly among cases and controls. A-allele carriers had a higher relative risk of PCa (OR = 3.6, 95% CI 2.0-6.4) compared to C-only carriers. AC and AA genotypes had an increased risk of PCa (OR = 3.8, 95% CI 2.1-6.8 and OR = 1.7, 95% CI 0.4-6.6, respectively) compared to CC genotypes. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:683 / 685
页数:3
相关论文
共 50 条
  • [1] -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer
    Jonsson, BA
    Adami, HO
    Hägglund, M
    Bergh, A
    Göransson, I
    Stattin, P
    Wiklund, F
    Grönberg, H
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) : 348 - 352
  • [2] A single nucleotide polymorphism in the E-cadherin gene promoter-160 C/A is associated with risk of nasopharyngeal cancer
    Ben Nasr, Hela
    Hamrita, Bechr
    Batbout, Mariem
    Gabbouj, Sallouha
    Bouaouina, Noureddine
    Chouchane, Lotfi
    Chahed, Karim
    CLINICA CHIMICA ACTA, 2010, 411 (17-18) : 1253 - 1257
  • [3] E-cadherin gene polymorphism and risk of urothelial cancer
    Tsukino, H
    Kuroda, Y
    Nakao, H
    Imai, H
    Inatomi, H
    Kohshi, K
    Osada, Y
    Katoh, T
    CANCER LETTERS, 2003, 195 (01) : 53 - 58
  • [4] Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population
    Kamoto, T
    Isogawa, Y
    Shimizu, Y
    Minamiguchi, S
    Kinoshita, H
    Kakehi, Y
    Mitsumori, K
    Yamamoto, S
    Habuchi, T
    Kato, T
    Ogawa, O
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (03) : 158 - 161
  • [5] Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies
    Chang, Zheng
    Zhou, Hongbing
    Liu, Yi
    TUMOR BIOLOGY, 2014, 35 (10) : 10503 - 10513
  • [6] Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer
    Tsukino, H
    Kuroda, Y
    Imai, H
    Nakao, H
    Qiu, D
    Komiya, Y
    Inatomi, H
    Hamasaki, T
    Kohshi, K
    Osada, Y
    Katoh, T
    UROLOGIA INTERNATIONALIS, 2004, 72 (03) : 203 - 207
  • [7] Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan
    Kuraoka, K
    Oue, N
    Yokozaki, H
    Kitadai, Y
    Ito, R
    Nakayama, H
    Yasui, W
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (02) : 421 - 427
  • [8] Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder
    Zhang, X
    Ma, X
    Zhu, QG
    Li, LC
    Chen, Z
    Ye, ZQ
    JOURNAL OF UROLOGY, 2003, 170 (04) : 1379 - 1382
  • [9] E-cadherin gene 3′-UTR C/T polymorphism is associated with prostate cancer
    Wu, HC
    Lai, MT
    Wu, CI
    Chen, HY
    Wan, L
    Tsai, FJ
    Chen, WC
    UROLOGIA INTERNATIONALIS, 2005, 75 (04) : 350 - 353
  • [10] E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patients
    Li, He-Cheng
    Albert, Jeffrey M.
    Shinohara, Eric T.
    Cai, Qiuyin
    Freyer, Andrea
    Cai, Hui
    Cao, Carolyn
    Wang, Zuofei
    Kataoka, Nobuhiko
    Teng, Ming
    Zheng, Wei
    Lu, Bo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (06) : 496 - 502